Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry.

Guilherme F AttizaniLuis Augusto P DallanJohn K ForrestMichael J ReardonWilson Y SzetoFang LiuMarc Pelletier

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)

Results from the TVT Registry demonstrate good short-term outcomes after redo-TAVR with the supra-annular, self-expandable Evolut platform. Long-term follow-up is necessary to further expand understanding this complex scenario.

Keyphrases

transcatheter aortic valve replacement
transcatheter aortic valve implantation
aortic valve replacement
aortic stenosis
aortic valve
high throughput
ejection fraction
left ventricular
coronary artery disease
heart failure
cell therapy